SSII Company Profile and Key Details

SSII has shown mixed momentum, gaining 4.11% over the past week and -42.81% over the past quarter, though year-to-date performance is down -1.94%. Short-term trend indicators are bullishly aligned (SMA20 13.05%, SMA50 -4.79%, SMA200 -24.48%). The stock’s 14-day RSI is 51.66 (neutral), while the ATR of 0.58 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -78.81% below its high and over 57.55% above its low. Average 10-day trading volume of 47.40 thousand shares is below the 3-month average of 97.04 thousand, indicating normal recent market interest.

SS Innovations International, Inc. generated EPS of -$0.06 over the past year. Five-year average earnings growth is 41.03%.

SS Innovations International, Inc. has 193.60 million shares outstanding. The public float is 31.55 million shares, elevated short interest at 0.21% of float. This equals 97.85 thousand shares. The short ratio is 0.85 days. Institutional investors hold 1.21% of the float. Insiders own 83.03%. Sudhir Srivastava holds 109.85 million shares, MOLL FREDERIC H has 10.78 million shares and Cohen Barry F has 8.87 million shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

SS Innovations International, Inc. (NASDAQ:SSII) closed at $4.83 USD, losing -$0.07 (-1.43%) from the previous close of $4.90. The stock is currently mid-range between its 52-week high and low $3.02 and $22.42. With a market capitalization of about $938.74 million, SS Innovations International, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~1.64). Key stats such as the average daily volume over the past year has been around 97.68 thousand shares, volume is running light vs its 52-week average. Headquartered in Fort Lauderdale, FL, SS Innovations International, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Sudhir Prem Srivastava, the company employs approximately 378 people and listed since October 17, 2018. SS Innovations International, Inc. develops surgical robotic systems.

SS Innovations International, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.90. This means the shares are trading below this model’s fair value.

SS Innovations International, Inc. trades at a P/E ratio of -76.93, slightly below the S&P 500 average, with a price-to-sales ratio of 22.47 and a price-to-book ratio of 24.41 reflecting a rich premium to book value. The P/FCF stands at -42.98, also below market averages. Compared to sector medians, SS Innovations International, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Our AI price prediction model suggests that SS Innovations International, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 6.94%, with price expected at $5.24 by April 06, 2026, within a range of $4.81 to $5.63 3-Month Outlook: Projected fall of -86.73%, reaching $0.65 by June 19, 2026, with a range of $0.48 to $0.80. 1-Year Outlook: Projected loss of -83.06%, with price at $0.83 by March 23, 2027, within a range of $0.68 to $0.96.

SS Innovations International, Inc. (NASDAQ:SSII) shares are flat -1.94% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows SS Innovations International, Inc. trading at a premium to the broader market with a P/E of -76.93. Our AI forecast model points to short-term strength (6.94% over two weeks), a medium-term fall (-86.73% over three months), and a longer-term loss (-83.06% over one year), with expected trading ranges indicating moderate volatility.